Financial Incentives for Smoking Cessation Treatment Engagement

NCT04601870 | Completed Results

• 5 other identifiers: 2020-0717A534253SMPH/MEDICINE/GEN INT MDProtocol Version 1/6/20213R35CA197573-06S1
• Study Type: interventional
• Target: 98
• Locations: 1 country
• Sites: 1

Brief Summary

This study is being done to see if financial incentives increase the rate at which smokers engage in cessation treatment. A total of 540 participants will be enrolled by invitation from 6 primary care clinics of the participating healthcare system. Participants will be in the study for approximately 28 weeks.

Conditions

Quitting Smoking

Keywords

smoking cessation; financial incentives

Outcome Measures

Primary Outcomes (1)

• Number of Participants Who Set A Target Quit Date (TQD) and Complete Phone Counseling

  The relation between treatment engagement financial incentive amounts offered and likelihood of patient engagement in smoking cessation treatment will be assessed by the number of participants who set a TQD and complete two phone counseling calls.

  up to 60 days from enrollment

Other Outcomes (1)

• 6 Month Smoking Abstinence Rates

  Biochemical confirmation of abstinence occurred within 1-9 days following completion of 6-month post quit date follow-up.

Study Arms (3)

No Financial Incentive

EXPERIMENTAL

N=180 participants randomized to not be offered monetary incentive to participate in an intervention to quit smoking.

Other: No Financial Incentive

Financial Incentive (100 dollars)

EXPERIMENTAL

N=180 randomized participants will be offered a 100 dollar incentive to participate in an intervention to quit smoking.

Other: Financial Incentive (100 dollars)

Financial Incentive (50 dollars)

EXPERIMENTAL

N=180 randomized participants will be offered a 50 dollar incentive to participant in an intervention to quit smoking.

Other: Financial Incentive (50 dollars)

Interventions

No Financial Incentive OTHER

No monetary incentive to participate in quit planning and quit counseling with a tobacco cessation specialist.

No Financial Incentive

Financial Incentive (100 dollars) OTHER

Financial incentive (100 dollars) to participate in quit planning and quit counseling with a tobacco cessation specialist.

Financial Incentive (100 dollars)

Financial Incentive (50 dollars) OTHER

Financial incentive (50 dollars) to participate in quit planning and quit counseling with a tobacco cessation specialist.

Financial Incentive (50 dollars)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• On Cigarette User Registry at a participating clinic
• Able to speak English or Spanish

You may not qualify if:

• Activated healthcare power of attorney or cognitive impairment that would preclude informed consent.
• Existing target quit date approximately 30 days from date of call to TCOS
• Current billable insurance status in EHR of Medicare or non-BadgerCare Medicaid
• Prior screening for Treatment Engagement incentive enrollment

Sponsors & Collaborators

• University of Wisconsin, Madison: lead
• National Cancer Institute (NCI): collaborator

Study Sites (1)

University of Wisconsin

Madison, Wisconsin, 53711, United States

Location

MeSH Terms

Conditions

Smoking Cessation

Condition Hierarchy (Ancestors)

Health Behavior; Behavior

Results Point of Contact

• Title: Mark Zehner
• Organization: University of Wisconsin-Madison School of Medicine and Public Health Center for Tobacco Research and Intervention

mark.zehner@ctri.wisc.edu

16082627568

Study Officials

• Michael C Fiore, MD, MPH, MBA

  University of Wisconsin, Madison

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: No
• Restrictive Agreement: No

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 19, 2020
• First Posted: October 26, 2020
• Study Start: February 19, 2021
• Primary Completion: December 23, 2021
• Study Completion: June 17, 2022
• Last Updated: January 25, 2023
• Results First Posted: January 25, 2023

Record last verified: 2022-12

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, SAP
• Time Frame: Beginning 12 months after publication of primary outcomes, and ending 5 years after that date.
• Access Criteria: Proposals should be directed to \[PI Michael Fiore, MD at UW-CTRI (mcf@ctri.wisc.edu)\]. If approved after review by regulatory counsel, requestors will enter into a formal data sharing agreement. Data will be shared via encrypted single-user file transmission protocol.

Locations

US (1)